Evidence map›Paper›PMID 30804446›Full record

ArticleScientific reports2019

Substituting the catalytic proline of 4-oxalocrotonate tautomerase with non-canonical analogues reveals a finely tuned catalytic system.

Michael S Lukesch, Tea Pavkov-Keller, Karl Gruber, Klaus Zangger, Birgit Wiltschi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Michael S LukeschGraz University of Technology, Institute of Molecular Biotechnology, Petersgasse 14, 8010, Graz, Austria.
Tea Pavkov-KellerInstitute of Molecular Biosciences, University of Graz, Humboldtstraße 50, 8010, Graz, Austria.
Karl GruberInstitute of Molecular Biosciences, University of Graz, Humboldtstraße 50, 8010, Graz, Austria.ORCID 0000-0002-3485-9740
Klaus ZanggerInstitute of Chemistry, University of Graz, Heinrichstrasse 28, 8010, Graz, Austria.
Birgit WiltschiAustrian Centre of Industrial Biotechnology, Petersgasse 14, 8010, Graz, Austria. birgit.wiltschi@acib.at.
University of Graz · ATAustrian Centre of Industrial Biotechnology (Austria) · ATInstitute of Molecular Biotechnology · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The enzyme 4-oxalocrotonate tautomerase shows remarkable catalytic versatility due to the secondary amine of its N-terminal proline moiety. In this work, we incorporated a range of proline analogues into the enzyme and examined the effects on structure and activity. While the structure of the enzyme remained unperturbed, its promiscuous Michael-type activity was severely affected. This finding demonstrates how atomic changes in a biocatalytic system can abolish its activity. Our work provides a toolbox for successful generation of enzyme variants with non-canonical catalytic proline analogues.

Indexed as

AnimalsBiocatalysisCatalysisHumansIsomerasesProline4-oxalocrotonate tautomeraseIsomerasesProline

Identifiers

PMID30804446
PMCPMC6389900
OpenAlexW2915839530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.